Physician profile
Rudolph A Mason
NPI 1295851087
$7,211.63
in general payments reported to CMS, 2019-2025
5 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what 84% of Preventive Medicine/Occupational Environmental Medicine providers received nationally (typical 2025 total: $76.00).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.70 · 2021: $5,169 · 2022: $143 · 2023: $659 · 2024: $165 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218 · Travel and Lodging: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,217.67 |
| Travel and Lodging | $614.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $5,269.80 | 2021-2025 | Xcell, Durolane |
| United Orthopedics LLC | $1,580.64 | 2021-2023 | |
| Arthrex, INC. | $278.08 | 2023 | |
| Tenex Health INC. | $67.70 | 2019 | |
| Averitas Pharma INC. | $15.41 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rudolph Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.